Patent Grant
8771176
The present disclosure is directed to an ingestible capsule and a method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being using such ingestible capsule.
Ingestible capsules or medical devices for imaging the gastrointestinal tract of mammals (animals or human beings) have been disclosed in the prior art, such as, in U.S. Pat. Nos. 5,604,531; 6,855,111; and 6,950,690; U.S. Patent Applications 2006/0082648 (published Apr. 20, 2006); 2005/0137468 (published Jun. 23, 2005); 2005/0002945 (published Jan. 6, 2005); and 2006/0100486 (published May 11, 2006); and PCT Publications WO 2004/051323 (published Jun. 17, 2004); WO 2002/306007 (published May 10, 2002); and WO 2002/058531 (published Aug. 1, 2002).
Typically, a capsule camera is adapted for in vivo imaging within a patient's body after ingestion thereof, taking image scenes of, for example, the gastro-intestinal tract. A conventional capsule camera (see
In WO 2004/051323, a variable lens system is described that is placed in front of the sensor, thereby allowing variable focus/zooming and/or variable directed imaging function in a compact, low power consumption and lightweight module. Only imaging functionality is addressed in this publication, allowing in some cases diagnoses of diseases of the gastrointestinal tract. Further inspection or the treatment of these diseases with light is not addressed. In order to allow optical treatment with light, the area to be treated must be identified and, once the treatment area has been identified, the light beam must be focused on this area and kept in focus for some time while the capsule moves along.
Another problem arises when a certain area of interest is to be further inspected with optical methods requiring a focused light beam to be aimed at the area-of-interest while the capsule moves along. With the noted prior art devices, focused inspection is not possible because the light beam is a broad field illumination beam.
Despite efforts to date, a need remains for ingestible devices and/or an ingestible systems that facilitate effective focus of a light beam on a desired in vivo location, e.g., an identified lesion, either for treatment or for further inspection. In addition, a need remains for an apparatus and/or system that facilitates in vivo light focus and/or beam steering in connection with a capsule camera.
These and other needs are satisfied with the devices, systems and methods of the present disclosure.
According to the present disclosure, an ingestible capsule and method for in vivo imaging and/or treatment of diseased tissue in the gastrointestinal tract of an animal or human being is disclosed. The capsule comprises an image sensor; a lens system for focusing images onto the image sensor; at least one light source, and preferably first and second light sources, for illumination of the tissue area of interest, the second light source optionally being capable of providing optical therapeutic treatment to the diseased areas; a variable lens system located in front of the first light source, wherein the variable lens system comprises beam steering means and focusing means for directing and focusing the light beams from the first light source onto the diseased tissue areas; a control unit in communication with the image sensor, first and second light sources, and variable lens system, the control unit comprising image storing means, processing means and image transmission means; wherein the control unit correlates stored images received from the image sensor as the capsule travels through the gastrointestinal tract and controls the beam steering means and focusing means of the variable lens system to ensure that the light beams from the first light source are directed and focused onto the diseased tissue areas; a power source for powering the image sensor, the first and second light sources and the control unit; and a non-digestible, transparent outer protective shell configured to pass through the gastrointestinal tract, housing within the image sensor, the lens system, the first and second light sources, the variable lens system, the control unit and the power source.
Specifically it is an object of the invention to provide an ingestible capsule for in vivo imaging and/or treatment of one or more diseased tissue areas of interest within the gastrointestinal tract of an animal or human being, said capsule comprising:
Another object is to provide an ingestible capsule for in vivo imaging and/or treatment of one or more diseased tissue areas of interest within the gastrointestinal tract of an animal or human being, said capsule comprising:
Another object is to provide a capsule wherein the first and second light sources are each lasers.
Another object is to provide a capsule wherein the variable lens system comprises a liquid lens system.
Another object is to provide a method for in vivo imaging of one or more tissue areas of interest within the gastrointestinal tract of an animal or human being comprising: ingesting a capsule comprising:
Another object is to provide a method for in vivo imaging of one or more tissue areas of interest within the gastrointestinal tract of an animal or human being comprising: ingesting a capsule comprising:
Another object is to provide a method for in vivo treatment of one or more diseased tissue areas of interest within the gastrointestinal tract of an animal or human being comprising:
Another object is to provide a method for in vivo treatment of one or more diseased tissue areas of interest within the gastrointestinal tract of an animal or human being comprising:
Another object is to provide a method wherein the first and second light sources are each lasers.
Another object is to provide a method wherein the variable lens system comprises a liquid lens system.
Another object is to provide a method wherein the treatment comprises thermo-ablation of a lesion or tumor; or coagulation of a bleeding blood vessel or bleeding tumor.
These and other aspects of the invention are explained in more detail with reference to the following embodiments and with reference to the figures.
To overcome the problems associated with prior disclosed medical devices and ingestible capsules, the herein disclosed ingestible capsule and method utilize a variable lens placed in front of the light source, for instance a liquid lens. The liquid lens has been discussed in detail in WO2003/069381. In order to allow beam steering, also additional electrodes have to be used on the exterior of the liquid lens described in WO2004/051323, which is incorporated by reference herein in its entirety. Although making use of a liquid enabling focusing and beam steering of the light beam, it still does not solve the problem of how to keep the focus spot on the tissue area to be treated or further inspected. To solve this problem we make use of the camera system, including 32 and 34, in combination with the illumination device 38. When 38 is switched on, the camera takes an image, from which the area of interest can be identified by the image processing unit 40 (see
In case of treatment, the requirement on diagnosing the right tissue area with the camera is important. To improve this step, fluorescence markers can be used. In this case the light source 38 is used also to illuminate the lesion to induce fluorescence by the targeted marker. Apart from fluorescence this can be generalized to include also autofluorescence/bioluminescence. By correlating the treatment spot with the fluorescence spot in the way described above, this modality can be used for aiming at the treatment spot. The fluorescence will also give an indication where ablation or other treatment has to be performed. Without it, the camera image needs to be analyzed in order to find the pathology. It is also possible to use multiple fluorescent labels which emit at different wavelengths and can thus provide information on different proteins in the lesion, which may require different treatments.
Exemplary Applications According to the Invention
Examples of Treatment.
When the treatment light source is a laser, a thermal effect on the lesion or tumor can be employed for thermo-ablation of the lesion or tumor. The thermal effect of the laser can also be used for coagulation of a bleeding vessel or the bleeding surface of a tumor.
Another example is that the light source is used as a source of non-thermal light for photodynamic therapy (PDT) (see for instance DEJC Dolmans, D Fukumura and RK Jain, “Photodynamic therapy for cancer”, in Nature Reviews Cancer 2003 vol. 3 page 380-387). This requires the use of photosensitiser agents. It is also possible that a photosentizing agent is locally released by the capsule when it detects a suspicious lesion (or on a continuous basis, which requires a larger reservoir).
Example of Further Investigation.
Confocal Microscopy
An example of an application according to the invention is employing confocal microscopy (see
In case of a confocal scanning microscope the light beam, produced by a laser 38, passes a partial beam splitter 60 and is aimed and focused by the liquid lens 44 on the lesion of interest. The reflected signal following the same return path is now focused by the liquid lens 44 via reflection on the partial beam splitter 60 onto the detector 62 via a pinhole or aperture present in front of the detector. By scanning the beam by changing the setting of the variable lens 44 an image with the confocal microscope of the lesion can be taken. In order to do proper image reconstruction, motion of the capsule has to be corrected for. This can be accomplished by using the capsule camera according to the invention.
Fluorescence Imaging
In case of fluorescence imaging process, the laser beam is brought in focus with the lesion or tumor. The fluorescence induced by the light absorption is detected by a detector module.
We can use for instance the same set-up as described for the confocal microscope. Since now we are looking for fluorescence produced by light absorption we adapt the detector in order to record the fluorescence light spectrally resolved.
Diffuse Optical Tomography (DOT)
In this case the light source consist of one or more light emitters that enable subsequent point like illumination of the adjacent tissue around the capsule that at least contains positions that are transparent for the light (see
Optical Coherence Tomography (OCT)
OCT is an imaging technology that achieves up to a few millimeters penetration depth (1.5-2 mm typically) at ultrahigh resolution (several microns) generating 3D tissue images in real time. OCT provides 3D structural image (tissue layers, density changes), showing currently great potential to provide spectroscopic information and to achieve functional and molecular imaging as well. OCT is an interferometry-based technology, capable of measuring signals as small as −90 dB. One standard fiber based OCT set-up is shown in
Light coming from a light source is split by a coupler. One arm serves as a sample (reference) arm of the interferometer, while the other one delivers light to the sample (sample arm). The scanning optics provides lateral scanning capabilities, so that the OCT set-up obtains one A-scan (axial-scan) for each lateral position. All A-scans combined form a 3D structural image. When obtaining each A-scan the reference mirror's displacement provides depth information. Several more advanced techniques have been developed to achieve depth information in shorter times than the one shown here. Spectroscopic OCT is the most advanced among those, providing depth scans data with no moving parts. Currently the fastest OCT systems can produce images on around 30 fps, with more than 1000 A-scans per frame. Lateral resolution is limited by the scanning optics and light focusing system. Axial resolution is light source dependent. A typical axial resolution currently accessible with commercial SLDs (super luminescence diodes, bandwidth around 70 nm at 930 nm) is approximately 5 μm. One of the best demonstrated resolutions of around 1.5 μm was achieved by using a Ti:sapphire fs laser.
To make this suitable for use in the capsule according to the invention the system has to be miniaturised. From the engine side OCT requires:
Although at the moment no such miniaturised device exist it is envisaged that in the near future miniaturisation allows the construction of such a device. For instance, a miniaturised probe design has been described in Optics Letters 29, 2261 (2004) (see
While the present invention has been described with respect to specific embodiments thereof, it will be recognized by those of ordinary skill in the art that many modifications, enhancements, and/or changes can be achieved without departing from the spirit and scope of the invention. Therefore, it is manifestly intended that the invention be limited only by the scope of the claims and equivalents thereof.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/IB2007/051323 | 4/12/2007 | WO | 00 | 1/21/2009 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2008/012701 | 1/31/2008 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 4951663 | L'Esperance, Jr. | Aug 1990 | A |
| 5098426 | Sklar et al. | Mar 1992 | A |
| 5604531 | Iddan et al. | Feb 1997 | A |
| 6240312 | Alfano et al. | May 2001 | B1 |
| 6855111 | Yokoi et al. | Feb 2005 | B2 |
| 6950690 | Meron et al. | Sep 2005 | B1 |
| 7022067 | Glukhovsky et al. | Apr 2006 | B2 |
| 7044908 | Montalbo et al. | May 2006 | B1 |
| 7530948 | Seibel et al. | May 2009 | B2 |
| 20010051766 | Gazdzinski | Dec 2001 | A1 |
| 20020006264 | Birk et al. | Jan 2002 | A1 |
| 20030208107 | Refael | Nov 2003 | A1 |
| 20040061072 | Gu et al. | Apr 2004 | A1 |
| 20040254474 | Seibel et al. | Dec 2004 | A1 |
| 20050002945 | McBride et al. | Jan 2005 | A1 |
| 20050043586 | Suzushima | Feb 2005 | A1 |
| 20050096712 | Abraham-Fuchs et al. | May 2005 | A1 |
| 20050137468 | Avron et al. | Jun 2005 | A1 |
| 20050215911 | Alfano et al. | Sep 2005 | A1 |
| 20060082648 | Iddan et al. | Apr 2006 | A1 |
| 20060100486 | Maschke | May 2006 | A1 |
| 20060195014 | Seibel et al. | Aug 2006 | A1 |
| 20060195015 | Mullick et al. | Aug 2006 | A1 |
| 20070066871 | Yang et al. | Mar 2007 | A1 |
| 20080103355 | Boyden et al. | May 2008 | A1 |
| 20090281389 | Iddan | Nov 2009 | A1 |
| Number | Date | Country |
|---|---|---|
| 0236007 | May 2002 | WO |
| 02058531 | Aug 2002 | WO |
| 2004051323 | Jun 2004 | WO |
| 2006070356 | Jul 2006 | WO |
| Entry |
|---|
| Dolmans et al., “Photodynamic therapy for cancer”, Nature Reviews Cancer 2003, pp. 380-387, vol. 3. |
| Gibson et al., “Recent advances in diffuse optical imaging”, Phys. Med. Biol., 2005, R1-R43, vol. 50. |
| Herz, P.R. et al. “Micromotor Endoscope Catheter for Invivo, Ultrahigh-Resolution Optical Coherence Tomography”, OPTICS Letters, vol. 29, No. 19, Oct. 2004, pp. 2261-2263. |
| Number | Date | Country | |
|---|---|---|---|
| 20090177033 A1 | Jul 2009 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60820124 | Jul 2006 | US |
